Fundraising Fox

Ukko

Mountain View, US · Founded 2016 · Delaware corporation · 6 known investors

ukko.us ↗

Ukko develops immuno-therapeutics for life-threatening food allergies using a computational protein design platform. It applies AI and protein micro-engineering to create modified allergens that retrain the immune system to tolerate the allergen without triggering an allergic response.

AI & Machine LearningBiotechDigital Healthin /ukkoinc

Founders & leadership

JW
Judith Weiss PaltielPhD, VP Development
AB
Anat BinurExecutive Officer, Director
YO
Yanay OfranDirector
SB
Scott BradyDirector
SK
Samir KaulDirector

Investors · 6

Israel Biotech FundRehovot
Khosla VenturesMenlo Park · $5K – $50M
Sanara CapitalRa'ananavia Assaf Barnea · inferred
Western Technology InvestmentPortola Valley · $250K – $30M
Fall Line CapitalreportedSan Francisco
PeakBridge VCreportedUtrecht

Reported raises · per SEC filings

Form D private placements
▶$7.7MraisedJul 2017 · 5 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • Anat BinurExecutive Officer, Director
  • Yanay OfranDirector
  • Scott BradyDirector
  • Samir KaulDirector
Offering amount
$7.7M
Amount sold
$7.7M
First sale
Jul 2017
Incorporated
Corporation, Delaware, 2016
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.